Flexible Ureterorenoscopy for Surveillance of Upper Tract Urothelial Carcinoma
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Flexible ureterorenoscopy.
- Who it may be relevant to
- Registry conditions: Upper Tract Urothelial Carcinoma. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Hong Kong
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Flexible Ureterorenoscopy for Surveillance of Upper Tract Urothelial Carcinoma - A Pilot Study
Overview
It is a prospective single-arm pilot study to investigate the safety and feasibility of flexible ureteroscopy under local anaesthesia.
Detailed description
All consecutive patients who have undergone kidney-sparing surgery for managing upper tract urothelial carcinoma will be screened for study eligibility. Surveillance flexible ureteroscopy of the upper urinary tract under local anaesthesia in an ambulatory care setting. The peri-operative outcomes, patient reported outcomes, complication and cost-effectiveness analysis will be evaluated.
Interventions
- Other Flexible ureterorenoscopy
Flexible ureterorenoscopy for Surveillance of UTUC under local anaesthesia
Primary outcome measures
- Procedure success rate [Time frame: Immediately postoperatively]
Secondary outcome measures (2)
- Complication rate [Time frame: On day 30]
- Readmission rate [Time frame: On Day 30]
Eligibility criteria
Inclusion criteria
- Aged 18 years or older
- Capable of giving informed consent
- Having undergone an kidney-sparing surgery (endoscopic operation or segmental ureterectomy)
Exclusion criteria
- Allergy to transurethral lidocaine jelly
- On anticoagulation or anti-platelet medication with contraindications for cessation prior to the procedure
- Structural abnormalities in the upper urinary tract on the intended side of examination
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
Hong Kong · 1 center
- Prince of Wales Hospital — Hong Kong
Identifiers
NCT: NCT07557563 · CRE-2024.432